Mrv0541 01081412322D 28 29 0 0 0 0 999 V2000 -0.4350 -8.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9688 -8.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2669 -7.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4350 -9.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9688 -9.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2669 -9.5830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.2075 -6.6722 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 0.2669 -7.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9688 -6.6722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1369 -7.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6707 -7.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5997 -5.9703 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 2.5997 -7.3947 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.1369 -7.0851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.8801 -8.3444 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6707 -7.0851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3726 -8.3444 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.1575 -9.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6707 -9.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4350 -6.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9688 -5.8671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4350 -5.8671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2669 -5.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5934 -7.9261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3107 -8.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3162 -9.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0224 -7.9166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0921 -7.9361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 0 0 0 0 4 1 2 0 0 0 0 10 1 1 0 0 0 0 3 2 1 0 0 0 0 11 2 1 0 0 0 0 5 2 2 0 0 0 0 3 8 1 0 0 0 0 6 4 1 0 0 0 0 18 4 1 0 0 0 0 6 5 1 0 0 0 0 19 5 1 0 0 0 0 9 7 1 0 0 0 0 12 7 1 0 0 0 0 13 7 2 0 0 0 0 9 8 1 0 0 0 0 20 8 2 0 0 0 0 21 9 2 0 0 0 0 14 10 2 0 0 0 0 15 10 1 0 0 0 0 16 11 2 0 0 0 0 17 11 1 0 0 0 0 22 20 1 0 0 0 0 23 21 1 0 0 0 0 23 22 2 0 0 0 0 15 24 1 0 0 0 0 24 25 1 0 0 0 0 25 26 1 0 0 0 0 25 27 1 0 0 0 0 17 28 1 0 0 0 0 M CHG 2 7 1 12 -1 M END > CHEBI:76917 > methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate > A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris. > 3 > methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate > C20H24N2O6 > 388.41440 > 388.16344 > 0 > COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C > InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3 > VKQFCGNPDRICFG-UHFFFAOYSA-N > 63675-72-9 > C07699 > D00618 > LSM-5172 $$$$